Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4096
-0.0127 (-3.01%)
At close: Feb 18, 2026, 4:00 PM EST
0.4190
+0.0094 (2.29%)
Pre-market: Feb 19, 2026, 7:23 AM EST
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $30.11 million as of February 19, 2026. Its market cap has decreased by -49.17% in one year.
Market Cap
30.11M
Enterprise Value
52.22M
1-Year Change
-49.17%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $30.11M, a decrease of -69.08%. That is a compound annual growth rate of -11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 30.11M | -70.28% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 31.98M |
| Tempest Therapeutics | 31.95M |
| Palatin Technologies | 31.82M |
| Lantern Pharma | 31.09M |
| Reviva Pharmaceuticals Holdings | 29.80M |
| Rein Therapeutics | 29.70M |
| Dyadic International | 29.67M |
| Hyperion DeFi | 29.56M |